...
首页> 外文期刊>Expert opinion on therapeutic targets >Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS
【24h】

Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS

机译:蛋白质二硫化物异构酶:PDI和ERP57在神经系统中的新兴作用以及ALS的治疗靶标

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: There is increasing evidence that endoplasmic reticulum (ER) chaperones Protein Disulphide Isomerase (PDI) and ERp57 (endoplasmic reticulum protein 57) are protective against neurodegenerative diseases related to protein misfolding, including Amyotrophic Lateral Sclerosis (ALS). PDI and ERp57 also possess disulphide interchange activity, in which protein disulphide bonds are oxidized, reduced and isomerized, to form their native conformation. Recently, missense and intronic variants of PDI and ERp57 were associated with ALS, implying that PDI proteins are relevant to ALS pathology.
机译:介绍:增加证据表明,内质网(ER)伴侣蛋白二硫化物异构酶(PDI)和ERP57(内质网蛋白57)对与蛋白质错误折叠相关的神经变性疾病,包括肌萎缩侧面硬化(ALS)。 PDI和ERP57还具有二硫化物互换活性,其中蛋白质二硫化物键被氧化,减少和异构化,形成其天然构象。 最近,PDI和ERP57的脑电和内肾上腺素与ALS相关,暗示PDI蛋白与ALS病理相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号